stars 1 stars 2 stars 3

GENERIUM is a full-cycle innovative high-end pharmaceutical company. We are the leader in Russian orphan pharmaceutical market. GENERIUM possesses its own R&D park, which is capable to handle the full cycle of development of any biological drug, from molecule design to commercial production. We are collaborating in science with leading biotechnological companies and institutes from all over the world. GENERIUMs manufacturing facilities are equipped with high-end equipment. The work is organized under GMP standards and our plants are ready to produce any kind of biological drugs or ATMPs. Our mission – our ideas to save life and health.

Generium Questions

The Generium annual revenue was $6.6 million in 2026.

Dmitry Sokolov is the CIO of Generium.

120 people are employed at Generium.

Generium is based in Vol ginskiy, Vladimir.

The NAICS codes for Generium are [52211, 522110, 5221, 522, 52].

The SIC codes for Generium are [60, 602].

Top Generium Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users